OliveBio

OliveBio is a California-based biotechnology startup focused on making polyhydroxyalkanoate (PHA) bioplastics a commercially viable and scalable alternative to traditional petrochemical plastics. The company utilizes an innovative, AI-guided, cell-free biocatalysis platform that employs specific enzymatic machinery rather than whole bacterial cells to produce PHA. This approach is designed to provide superior control over polymer architecture, including monomer ratios, sequencing, and chain length, while aiming to lower production costs, increase throughput, and ensure higher consistency compared to traditional fermentation methods.

By overcoming the economic barriers that have historically limited the adoption of bioplastics, OliveBio aims to transform the plastics industry by developing sustainable, non-toxic, and versatile PHA-based materials. These biopolymers are designed to be home-compostable and marine-degradable, utilizing renewable or waste-based feedstocks. The company, which is a member of the Global Organization for PHA (GO!PHA), works to provide tailored solutions for various applications, ranging from biomedical materials to industrial plastics, ultimately supporting the transition to a circular economy.